Thanks Dan
If Allergan stated that shareholders of record on OCT 27th would be the ones to vote at the meeting, then is it fair to say "hard powers" will be exhausted before then to try to drive the arbs, etc out of a voting position? Should Allergan be expediting the use of said hard powers to before the Oct court hearing?
Also, unclear if the special meeting is to replace or "remove" directors. Is it a foregone conclusion that PS slate would be in if others were out or is could a new set of directos come in that is not PS's? If a new set what would be the timing and who would nominate them?
